Modular Robotic Surgery System Cleared for General Surgery Procedures

By HospiMedica International staff writers
Posted on 19 Nov 2026

Upper and lower abdominal procedures, including cholecystectomy, hernia repair, small-bowel resection, and gastric bypass, account for approximately 3.5 million operations annually in the U.S., representing more than half of all soft-tissue surgeries. As health systems increasingly adopt robotic platforms to improve operating room coordination and flexibility, a new system is expanding robotic-assisted surgical options for these common procedures.

The Hugo robotic-assisted surgery (RAS) system from Medtronic has received expanded 510(k) clearance from the U.S. Food and Drug Administration (FDA) for general surgery. The modular platform, intended for soft‑tissue surgery, uses independent robotic arms that surgical teams can deploy as needed for a given operation and patient anatomy. An open console keeps the surgeon visually connected with the operating room team and patient throughout the case.


Image: The Hugo robotic-assisted surgery system uses independent robotic arms for soft-tissue procedures and supports integration with established surgical tools. (Photo courtesy of Medtronic)

The system’s design supports integration with established tools, including the LigaSure RAS Maryland instrument, bringing vessel‑sealing technology used in more than 45 million open and laparoscopic procedures to the robotic platform. These elements are intended to give teams flexibility in instrument selection and room setup without committing to a fixed configuration. The approach aligns with hospitals’ needs to tailor workflows across a broad range of procedures.

The expanded clearance covers all upper abdominal general surgical procedures, including but not limited to cholecystectomy, Roux‑en‑Y gastric bypass, ventral hernia, and small bowel resection. Additional lower abdominal procedures, including inguinal hernia and appendectomy, were also cleared. For U.S. hospitals, the authorization broadens the range of procedures that can be performed with the system beyond urology. Combined, these general surgery procedures represent a significant portion of nationwide surgical volume.

In the U.S., the Hugo RAS system is in clinical use at a growing number of health systems and hospitals. Globally, procedure growth on the platform is running at more than twice the robotic surgery market and is on track to surpass 50,000 procedures by the end of the company’s fiscal year. Outside the U.S., general surgery is the highest‑growth area for the system, surpassing urology and gynecology.

“For decades, Medtronic has partnered with general surgeons, and we’re bringing that same commitment to robotic surgery for U.S. customers. Hugo expands choice with a practical option to help hospitals address capacity and access challenges, while giving surgical teams more flexibility to meet patients’ needs across care settings,” said Matt Anderson, senior vice president and president of Medtronic’s Surgical business.


Latest Surgical Techniques News